OSR Health amends VXM01 license to allow $15M convertible note settlement after Nasdaq delisting

OSR Holdings, Inc.

OSR Health, Vaximm AG and BCM Europe AG signed Amendment No. 1 on Oct. 15, 2026 to the April 29, 2026 global exclusive license for VXM01.
The amendment adds Section 6.10, letting OSRH convert all or part of its unexercised $15,000,000 Equity Option into Convertible Notes that BCME or a third party buys at par.
Notes would be issued in four $3,750,000 tranches with fixed conversion prices of about $2.00, $3.00, $4.00 and $5.00 per share, not subject to reset.
Closing is no fewer than 20 Business Days after the Note Election Notice; failure to close within 10 Business Days after the scheduled closing withdraws the notice and reinstates the Equity Option.
The parties cited Nasdaq Staff's Aug. 19, 2026 delisting determination and acknowledged OSR Holdings changed its name to OSR Health, Inc.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.